Physician Wealth Advisors’s Biogen BIIB Stock Holding History

Physician Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.2K	Buy	112 +9	+9%	+$1.72K	﹤0.01%	609
2026 Q1	$18.9K	Buy	103 +50	+94%	+$9.21K	﹤0.01%	635
2025 Q4	$9.33K	Hold	53	–	–	﹤0.01%	797
2025 Q3	$7.42K	Buy	53 +11	+26%	+$1.49K	﹤0.01%	823
2025 Q2	$5.28K	Sell	42 -2	-5%	-$249	﹤0.01%	784
2025 Q1	$6.02K	Buy	44 +14	+47%	+$2K	﹤0.01%	706
2024 Q4	$4.59K	Buy	+30	New	+$5.06K	﹤0.01%	750

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

NGM

North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

Physician Wealth Advisors's BIIB Position: Q2 2026 in Review

Physician Wealth Advisors increased its Biogen (BIIB) stake by 8.7% in Q2 2026, buying an estimated $1.72K and bringing the position to 112 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #609.

Physician Wealth Advisors first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 205 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Physician Wealth Advisors held 112 shares of Biogen worth $24.2K as of Q2 2026.
Physician Wealth Advisors bought 9 Biogen shares in Q2 2026, an estimated $1.72K.
Biogen made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #609 holding.
Physician Wealth Advisors first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
205 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.